Suchergebnis | Hamburg Open Science

Facetten

2 Einträge gefunden

Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab:an open-label phase 3 trial (MIRAI)
2019 - Forschungsinformationssystem des UKE
Independent replication of STAT3 association with multiple sclerosis risk in a large German case-control sample.
2012 - Forschungsinformationssystem des UKE